SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Reduced by Penserra Capital Management LLC

Penserra Capital Management LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 41,296 shares of the exchange traded fund’s stock after selling 1,521 shares during the quarter. Penserra Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $4,080,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in XBI. Fifth Third Bancorp increased its stake in shares of SPDR S&P Biotech ETF by 3.4% during the second quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after acquiring an additional 3,922 shares during the period. PFG Investments LLC raised its stake in shares of SPDR S&P Biotech ETF by 9.2% in the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after buying an additional 2,097 shares in the last quarter. IFG Advisory LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at $241,000. Beaton Management Co. Inc. bought a new position in SPDR S&P Biotech ETF during the third quarter valued at about $212,000. Finally, Atria Wealth Solutions Inc. grew its holdings in SPDR S&P Biotech ETF by 56.1% during the second quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock worth $1,539,000 after acquiring an additional 5,962 shares during the period.

SPDR S&P Biotech ETF Trading Up 2.1 %

Shares of SPDR S&P Biotech ETF stock opened at $96.24 on Monday. SPDR S&P Biotech ETF has a 52 week low of $71.99 and a 52 week high of $105.47. The company’s 50-day moving average price is $98.44 and its two-hundred day moving average price is $96.32. The stock has a market cap of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.